Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 791-794, October 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kit, S.
Right arrow Articles by Greenberg, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kit, S.
Right arrow Articles by Greenberg, D. M.

Tracer Studies on the Metabolism of the Gardner Lymphosarcoma

IV. The Conversion of Lactate-2-C14 to Alanine, Glutamate, and Aspartate by Tumor and Spleen Cells*

Saul Kit{dagger} and David M. Greenberg

( Division of Biochemistry, School of Medicine, University of California, Berkeley, Calif.)

When mouse lymphosarcoma or spleen cells were incubated with lactate-2-C14, significant radioactivity was found in the respiratory CO2. The only amino acids strongly labeled were alanine, glutamate, and aspartate; and the protein was also significantly labeled. Negligible radioactivity was found in the fats. In the spleen cells, the glutamate and aspartate contained almost equal radioactivity, while the alanine was less radioactive. On the other hand, in the lymphosarcoma cells the alanine had twice as much radioactivity and the aspartate one-fifth as much as the glutamate.

* Aided by research grants from the American Cancer Society, on recommendation by the Committee on Growth of the National Research Council, the National Cancer Institute, Public Health Service, and the Hobson Fund of the Cancer Research Institute, University of California School of Medicine.

{dagger} Predoctoral Research Fellow, National Cancer Institute, National Institutes of Health, Public Health Service, 1950–51.

Present address: Chemical Division, Dept. of Medicine, University of Chicago, Chicago, Ill.

Received 6/25/51.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.